论文部分内容阅读
BACKGROUND:Non-Hodgkins Lymphoma is one of the highly invasion tumor in hematology, with the amazing growth rate and complex pathology characteristics.More than 50%-60% patients with aggressive B-cell NHL(B-NHL) who achieved complete remission in initial treatment relapse after a few months or a few years,there is still part of the patients who are far beyond the standard of first-line could not received effective treatment.